Nigerian drugmakers’ finance costs surged by 47% in Q1 2026 due to high interest rates, impacting profitability. Learn how local pharma companies are navig Read More: https://punchng.com/drugmakers-finance-costs-jump-47-amid-high-interest-rates/
Nigerian drugmakers’ finance costs surged by 47% in Q1 2026 due to high interest rates, impacting profitability. Learn how local pharma companies are navig Read More: https://punchng.com/drugmakers-finance-costs-jump-47-amid-high-interest-rates/
This story was indexed from the original publisher.
Read at Punch